These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12094764)

  • 61. [Mechanism of the development of cardiac hypertrophy in essential hypertrophy].
    Kawaguchi H; Yasuda H
    Nihon Rinsho; 1992 Apr; 50 Suppl():594-601. PubMed ID: 1386126
    [No Abstract]   [Full Text] [Related]  

  • 62. The sympathetic myocardial innervation in various forms of experimental cardiac hypertrophy. A histochemical and ultrastructural study.
    Unge G; Mandache E; Ljungqvist A
    Acta Pathol Microbiol Scand A; 1973 May; 81(3):366-75. PubMed ID: 4767229
    [No Abstract]   [Full Text] [Related]  

  • 63. [Gene therapy for portal hypertension].
    Cañedo Chávez S
    Rev Invest Clin; 2000; 52(4):380-2. PubMed ID: 11061098
    [No Abstract]   [Full Text] [Related]  

  • 64. [Development of compensatory cardiac hypertrophy under the influence of monoethanolamine].
    Samvelian VM; Dzhanpoladian EG
    Patol Fiziol Eksp Ter; 1972; 16(3):86-7. PubMed ID: 4262188
    [No Abstract]   [Full Text] [Related]  

  • 65. Nitric oxide and cardiac function.
    Kelly RA; Balligand JL; Smith TW
    Circ Res; 1996 Sep; 79(3):363-80. PubMed ID: 8781470
    [No Abstract]   [Full Text] [Related]  

  • 66. [ARGININE METABOLISM IN HYPERTROPHIC AND HYPERPLASTIC KIDNEY TISSUE AND MYOCARDIUM IN COMPENSATORY HYPERTROPHY OF THE HEART FOLLOWING RENAL HYPERTENSION].
    BOGATZKI M
    Z Gesamte Exp Med; 1963 Sep; 137():256-62. PubMed ID: 14088633
    [No Abstract]   [Full Text] [Related]  

  • 67. [Inhibition of cell proliferation in the aortic wall and heart by cinnarizine (Stutgeron) in experimental renal hypertension in animal experiments].
    Schmitt G; Skrobek R; Hauss WH
    Verh Dtsch Ges Kreislaufforsch; 1974; 40():191-5. PubMed ID: 4450648
    [No Abstract]   [Full Text] [Related]  

  • 68. Cardiac hypertrophy and oxidative stress: a leap of faith or stark reality?
    Lang D
    Heart; 2002 Apr; 87(4):316-7. PubMed ID: 11906997
    [No Abstract]   [Full Text] [Related]  

  • 69. Increased monomine oxidase activity during the development of cardiac hypertrophy in the rat.
    de Chaplain J; Krakoff LR; Axelrod J
    Circ Res; 1968 Sep; 23(3):361-9. PubMed ID: 4234068
    [No Abstract]   [Full Text] [Related]  

  • 70. Production of cardiac hypertrophy and failure in rabbits with Ameroid clips.
    Sordahl LA; Wood WG; Schwartz A
    J Mol Cell Cardiol; 1970 Sep; 1(3):341-4. PubMed ID: 4255276
    [No Abstract]   [Full Text] [Related]  

  • 71. [Mechanisms of development of experimental cardiac hypertrophy and insufficiency].
    Frolov VA; Kazanskaia TA
    Kardiologiia; 1973 Jan; 13(1):54-9. PubMed ID: 4272271
    [No Abstract]   [Full Text] [Related]  

  • 72. [Cardiac tissue metabolism in the rat in renal hypertension].
    LACROIX E; LEUSEN I
    Arch Int Physiol Biochim; 1961 Feb; 69():114-7. PubMed ID: 13758122
    [No Abstract]   [Full Text] [Related]  

  • 73. [A method for obtaining experimental hypertrophy of the heart].
    Ovsepian SA
    Zh Eksp Klin Med; 1966; 6(2):3-7. PubMed ID: 4228729
    [No Abstract]   [Full Text] [Related]  

  • 74. Targeted deletion of neuronal nitric oxide: a step closer to understanding its functional significance?
    Good M
    Trends Neurosci; 1996 Mar; 19(3):83-4. PubMed ID: 9054058
    [No Abstract]   [Full Text] [Related]  

  • 75. [Pathogenesis of cardiac hypertrophy].
    DUTSCH L
    Med Klin; 1958 Feb; 53(9):355-8. PubMed ID: 13540870
    [No Abstract]   [Full Text] [Related]  

  • 76. [Significance of nitric oxide function in development of cardiac hypertrophy under condition of experimental renal hypertension].
    Tishchenko OV; Eliseeva EV; Motavkin PA
    Tsitologiia; 2002; 44(3):263-9. PubMed ID: 12094764
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
    Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Expression of nitric oxide and inducible nitric oxide synthase in acute renal allograft rejection in the rat.
    Suzuki A; Kudoh S; Mori K; Takahashi N; Suzuki T
    Int J Urol; 2004 Oct; 11(10):837-44. PubMed ID: 15479287
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Expression of nitric oxide synthase and nitric oxide-sensitive guanylate cyclase in the crustacean cardiac ganglion.
    Scholz NL; Labenia JS; de Vente J; Graubard K; Goy MF
    J Comp Neurol; 2002 Dec; 454(2):158-67. PubMed ID: 12412140
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Nitric oxide and the heart: update on new paradigms.
    Belge C; Massion PB; Pelat M; Balligand JL
    Ann N Y Acad Sci; 2005 Jun; 1047():173-82. PubMed ID: 16093495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.